Renal Failure Associated with the Use of Celecoxib and Rofecoxib
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 25 (7), 537-544
- https://doi.org/10.2165/00002018-200225070-00007
Abstract
Objective:Celecoxib and rofecoxib are two relatively new nonsteroidal anti-inflammatory drugs (NSAIDs) that selectively inhibit the cyclo-oxygenase-2 (COX-2) isoenzyme at therapeutic concentrations....Keywords
This publication has 34 references indexed in Scilit:
- Cyclo-Oxygenase-2 Inhibitors and the KidneyDrug Safety, 2002
- The Coxibs, Selective Inhibitors of Cyclooxygenase-2New England Journal of Medicine, 2001
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Effect of Cyclooxygenase-2 Inhibition on Renal Function in Elderly Persons Receiving a Low-Salt DietAnnals of Internal Medicine, 2000
- Are COX-2 selective inhibitors nephrotoxic?American Journal of Kidney Diseases, 2000
- The Medical Dictionary for Regulatory Activities (MedDRA)Drug Safety, 1999
- Nonsteroidal Anti-inflammatory Drugs and the Risk for Chronic Renal DiseaseAnnals of Internal Medicine, 1991
- Nonsteroidal Anti‐Inflammatory Drugs: Effects on Kidney FunctionThe Journal of Clinical Pharmacology, 1991
- Nonsteroidal anti-inflammatory drug nephrotoxicity. Should we be concerned?Archives of Internal Medicine, 1990